The M48 USV begins production: Can Magnet Defense convert 40,000 nautical miles of sea trials into a Navy contract?
Venture Global (NYSE: VG) and Edison settle Calcasieu Pass arbitration, agree to expand LNG deliveries to Italy
Herald Investment Trust (LSE: HRI) board races to build cash war chest as Saba standoff stretches into spring
Read More 2 minute read Pharma Industry News FDA accepts review of Kala Pharmaceuticals’ new dry eye treatment KPI-121 0.25% The United States Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for KPI-121 0.25%,… bypharmanewsdailyDecember 26, 2018